Search


 
 

23andMe Targets Mommies-to-Be

Posted by Jesse Reynolds on April 1st, 2009


The recreational and medical personal genetic testing company 23andMe has always used social networking as a key component of its service. Now it has added a group for expectant mothers, led by over a dozen prominent so-called "mommy bloggers," many of whom used assisted reproductive technologies to become pregnant.

I agree with Daniel MacArthur at Genetic Futures that this is "sheer marketing genius." There's no shortage of mothers and mothers-to-be with plenty of anxiety, internet access, disposable income, and - of course - spit.

Like much of 23andMe, its "Pregnancy Community" seems innocuous at first. As a new parent myself, I've played with an online eye color predictor.

But the endeavor brings to mind the likely near-term development of new methods of fetal genetic testing that will be noninvasive, inexpensive, and wide-ranging.

Already, a test to determine a future baby's sex using a sample of the mother's blood is available at the 5th week of pregnancy. One for Down Syndrome is on the way, as is a test for hundreds of conditions later in pregnancy.

23andMe tests for 28 medical conditions for only $400. How should we respond when dozens or even hundreds of genetic characteristics can be affordably tested after little more than a month of pregnancy?

Previously on Biopolitical Times:





Posted in Biotech & Pharma, Genetic Selection, Jesse Reynolds's Blog Posts, Personal genomics, Sex Selection


Comments

Add a Comment
 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications | about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 USA • • (p) 1.510.625.0819 • (F) 1.510.665.8760